| |
 |
|
Class Information
Number: 514/43
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring
Description: Subject matter wherein the aglycone portion contains a nitrogen containing hetero ring.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/52 |
Phosphorus containing (e.g., vitamin b12, etc.) |
258 |
| 514/44 |
Polynucleotide (e.g., rna, dna, etc.) |
3,242 |
| 514/45 |
Purines (including hydrogenated) (e.g., adenine, guanine, etc.) |
540 |
| 514/49 |
Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) |
504 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7323453 |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds |
Jan. 29, 2008 |
| 7323449 |
Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
Jan. 29, 2008 |
| 7323451 |
Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
Jan. 29, 2008 |
| 7319093 |
Antidiabetic 2-substituted-5'-O-(1-Boranotriphosphate) adenosine derivatives |
Jan. 15, 2008 |
| 7309696 |
Compositions and methods for targeting cancer cells |
Dec. 18, 2007 |
| 7297686 |
Chromium complex with insulin-like activity |
Nov. 20, 2007 |
| 7297683 |
Crystalline forms of an antiviral benzimidazole compound |
Nov. 20, 2007 |
| 7291603 |
Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
Nov. 6, 2007 |
| 7279465 |
Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases |
Oct. 9, 2007 |
| 7268119 |
Tricyclic nucleosides or nucleotides as therapeutic agents |
Sep. 11, 2007 |
| 7265096 |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
Sep. 4, 2007 |
| 7256179 |
Nucleic acid-based compounds and methods of use thereof |
Aug. 14, 2007 |
| 7247621 |
Antiviral phosphonate compounds and methods therefor |
Jul. 24, 2007 |
| 7244713 |
Nucleoside compounds for treating viral infections |
Jul. 17, 2007 |
| 7244716 |
Pharmaceutical composition of antiviral agents |
Jul. 17, 2007 |
| 7232805 |
Cobalamin conjugates for anti-tumor therapy |
Jun. 19, 2007 |
| 7223738 |
Inhibitors of Akt activity |
May. 29, 2007 |
| 7217730 |
Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
May. 15, 2007 |
| 7202223 |
Nucleoside compounds for treating viral infections |
Apr. 10, 2007 |
| 7202224 |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
Apr. 10, 2007 |
| 7192932 |
Use of immunomodulating agents |
Mar. 20, 2007 |
| 7173016 |
Composition and method for treating graft-versus-host disease |
Feb. 6, 2007 |
| 7173020 |
Phosphoramidates and methods therefor |
Feb. 6, 2007 |
| RE39464 |
Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages |
Jan. 9, 2007 |
| 7157441 |
Methods and compositions for treating hepatitis C virus |
Jan. 2, 2007 |
| 7157078 |
Devices and methods for eliminating termite colonies |
Jan. 2, 2007 |
| 7157434 |
Nucleoside compounds for treating viral infections |
Jan. 2, 2007 |
| 7151089 |
Nucleoside compounds for treating viral infections |
Dec. 19, 2006 |
| 7148206 |
Methods and compositions for treating flaviviruses and pestiviruses |
Dec. 12, 2006 |
| 7144868 |
Nucleoside compounds for treating viral infections |
Dec. 5, 2006 |
| 7144873 |
Kit for delivering decitabine in vivo |
Dec. 5, 2006 |
| 7138376 |
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
Nov. 21, 2006 |
| 7138377 |
Topoisomerase inhibitors |
Nov. 21, 2006 |
| 7138385 |
Thioarabinofuranosyl compounds and use thereof |
Nov. 21, 2006 |
| 7138384 |
Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
Nov. 21, 2006 |
| 7135464 |
Method of administering decitabine |
Nov. 14, 2006 |
| 7132408 |
Composition and method for inhibiting platelet aggregation |
Nov. 7, 2006 |
| 7125855 |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
Oct. 24, 2006 |
| 7122526 |
Indolocarbazole anticancer agents and methods of using same |
Oct. 17, 2006 |
| 7115578 |
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
Oct. 3, 2006 |
| 7115579 |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
Oct. 3, 2006 |
| 7107985 |
Pharmaceutical combination |
Sep. 19, 2006 |
| 7105493 |
Methods and compositions for treating flaviviruses and pestiviruses |
Sep. 12, 2006 |
| 7105495 |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
Sep. 12, 2006 |
| 7105499 |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
Sep. 12, 2006 |
| 7101860 |
Composition and method for inhibiting platelet aggregation |
Sep. 5, 2006 |
| 7091190 |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
Aug. 15, 2006 |
| 7081449 |
Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
Jul. 25, 2006 |
| 7081450 |
Water soluble nanoparticles of hydrophilic and hydrophobic active materials and an apparatus and method for their production |
Jul. 25, 2006 |
| 7074773 |
Pharmaceutical composition for diabetic neuropathy |
Jul. 11, 2006 |
|
|
|
